Persistent Identifier
|
doi:10.7910/DVN/6DSHMB |
Publication Date
|
2024-06-24 |
Title
| Replication Data for: Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya |
Author
| Lugano, DoreenKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Kutima, BernadetteKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Kimani, MakobuKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Sigilai, AntipaKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Gitonga, John N.KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Karani, AngelaKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Akech, DonaldKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Karia,BonifaceKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Wairimu, AngelaKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Lambisia, ArnoldKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Omuoyo, DonwilliamsKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Lucinde, RuthKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Ziraba, Abdhalah K.African Population and Health Research Center
Newman, JosephThe Pirbright Institute, Ash Road, Woking, GU24 0NF, Surrey, United Kingdom
Bailey, DalanThe Pirbright Institute, Ash Road, Woking, GU24 0NF, Surrey, United Kingdom
Githinji, GeorgeKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Agoti, Charles N.KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Sande, CharlesKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Kagucia, WangeciKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Ochola-Oyier, Lynette I.KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Bejon, PhilipKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Scott, J. Anthony G.KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Agweyu, AmbroseKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Warimwe, George M.KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Nyagwange, JamesKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya |
Point of Contact
|
Use email button above to contact.
Nyagwange, James (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)
The Data Governance Committee (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya) |
Description
| This is a replication dataset for the manuscript titled:Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya.
SARS-CoV-2 virus continues to mutate leading to emerging variants that escape immunity previously raised by vaccination and/or infection by earlier variants. We used genomic data to identify the most prevalent Kenyan and global variants between May 2023 and March 2024 and performed pseudoviruses neutralization assays on samples collected from two health demographic surveillance systems in Kenya (n=54), for vaccine induced immunity against circulating variants EG.5.1, FY.4 19, BA.2.86, JN.1, and JN.1.4. As a comparator, we used natural wildtype infection samples (n=20) collected in 2020 at the onset of the pandemic and confirmed to be PCR positive for SARS-CoV-2. We also assessed the effects of different doses of vaccine, age, sex, and type of vaccine on antibody-neutralizing titers. |
Subject
| Medicine, Health and Life Sciences |
Keyword
| SARS-CoV-2 variants
vaccination
neutralization
population immunity |
Related Publication
| Nyagwange, J. et al. Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases 127, (2023). Lambisia, A. W. et al. Detection of a SARS-CoV-2 Beta-like variant in coastal Kenya after more than a year of disappearance. Wellcome Open Res 8, (2023).
Mwanga, M. J. et al. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023. Emerg Infect Dis 29, (2023).
Githinji, G. et al. The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya. medRxiv (2022).
Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023).
Uyoga, S. et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science (1979) 371, (2021)
Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023) |
Notes
| Data Access : Data will be open access under the terms of the Creative Commons CC By 4.0 License. |
Depositor
| Lugano, Doreen |
Deposit Date
| 2024-06-24 |
Data Type
| Open Access |